about
The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic culturesGene delivery nanoparticles specific for human microvasculature and macrovasculature.2011 Rita Schaffer lecture: nanoparticles for intracellular nucleic acid delivery.Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumorsBiodegradable poly(amine-co-ester) terpolymers for targeted gene delivery.Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNAThe role of the helper lipid on the DNA transfection efficiency of lipopolyplex formulations.Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivoModulation of Silica Nanoparticle Uptake into Human Osteoblast Cells by Variation of the Ratio of Amino and Sulfonate Surface Groups: Effects of Serum.Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing.Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.Nanoparticles and their potential for application in bone.Targeted polymeric nanoparticles for cancer gene therapy.Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo.Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.Progress in microRNA delivery.Diabetic Retinopathy: Battling the Global Epidemic.Bioengineered nanoparticles for siRNA delivery.Electrostatic surface modifications to improve gene delivery.Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.Bone marrow-targeted liposomal carriersA comparison of peptide and folate receptor targeting of cancer cells: from single agent to nanoparticle.Polymer delivery systems for site-specific genome editingStrategies in biomimetic surface engineering of nanoparticles for biomedical applications.Therapeutic siRNA: principles, challenges, and strategies.Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapyNanodentistry: combining nanostructured materials and stem cells for dental tissue regeneration.siRNA therapeutics in the treatment of diseases.Genetic tools to manipulate MRI contrastSurface modification of nonviral nanocarriers for enhanced gene delivery.A sight on the current nanoparticle-based gene delivery vectors.Role of polymer-drug conjugates in organ-specific delivery systems.Magnetic nanoparticles: Applications in gene delivery and gene therapy.Biocompatibility and nanostructured materials: applications in nanomedicine.Non-viral nucleic acid containing nanoparticles as cancer therapeuticsEnhancing regenerative approaches with nanoparticles.Effects of surfactants on the properties of PLGA nanoparticles.Nanoparticles act as protein carriers during cellular internalization.High-affinity PEGylated polyacridine peptide polyplexes mediate potent in vivo gene expression.
P2860
Q30504481-AD73199F-20B0-48B6-8B73-0C207399DB75Q34150936-02E901D3-D78F-4AA7-8C14-D6407CD5245EQ34208751-ED3B6FEB-5105-4F00-B24E-5C353E1923B7Q34241923-FEF67700-C277-4DE3-A749-3D49B33A1C9BQ34271068-5BB3D323-EFFB-424E-B3D7-B031F7522208Q34433586-6B623010-121A-4C69-A2DE-267BF95EB748Q34539150-05343431-7770-46C1-AF9C-49A764DA2D5DQ34946937-EDE1C45C-4BC3-4BD9-87B1-7570E36C27FBQ35814950-43FBE755-94C5-4041-9A72-00DAE552D3B8Q35975665-9FD50F16-21AD-4996-9BC9-FEF2518ECABCQ36041260-9E3C8842-289D-43FD-9627-7D19D4FDB2D3Q36177552-BD117D37-CFE7-42A3-B049-EFA41F77D9F4Q36416427-3D5E6314-2F8B-42DC-8986-FEE01A2B39F8Q36759358-9E437DDA-3A37-419E-942C-11136CFE273CQ37019421-BDF59827-1DB5-4138-8D78-DAA5AC83282AQ37478933-C3586A59-F9EC-41FF-B10A-A3D6266A4E52Q37494858-85B02F71-330B-461C-99FA-0B1DE5731C95Q37679156-05CC7B8E-BEF0-4B50-8955-E926F0EB0BD5Q37702232-65ADCF1F-726D-4907-9995-4DF5A019C338Q37724374-7B237B69-EE79-4EC6-A262-CE1401C4BE60Q37833107-47728E02-6D61-4252-A0B9-6A5FE14C9398Q37838443-9FD67C0C-AA13-4E81-82A6-7E256F95C71CQ37881210-37A0C53A-99D6-4EF4-850D-10A3A8CA979EQ37963778-955C608E-80A0-4236-8AD3-2D6F1950B519Q38021996-8FB77186-21F3-45B8-9702-56E3EC29B5CFQ38028961-858AB683-9CE5-47C1-A39F-E9AC64D9D7B2Q38034961-ECEF9206-4471-497F-BC68-E8C3975E6DF9Q38064922-7DE7D598-5DFA-4DD9-AD1E-A15702C071EEQ38074462-16A1C0D9-979D-4FEC-88E0-6412C7A73837Q38077162-76D05A6A-1603-46E5-AF40-9CC49654BB19Q38172635-43962090-8BA4-419B-8C8C-B66D58A1148EQ38220813-BBE14A2D-FD09-4A44-971F-FA1BA5AFD04FQ38365556-78913EC2-66BA-4B6B-9C40-C3F2A2021A95Q38366410-4E1DA869-EC51-4880-B661-B8F523DBFD60Q38849743-7ABD9E54-4D02-4976-831E-8769C9F2B7B4Q38849963-4C87C6CC-44FA-4ED2-9E07-4EC0AAEC4B07Q39239110-DFA3DC41-1432-40BC-923B-B5E867B8C807Q39352101-778BABE0-CD8C-4EDE-B344-9690C5ED94DEQ39397417-4EB542ED-871E-4F28-8ECF-53398BA3C337Q41084198-F9111676-46F9-4CEB-825D-678F3BFFED43
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Tissue-specific gene delivery via nanoparticle coating.
@en
type
label
Tissue-specific gene delivery via nanoparticle coating.
@en
prefLabel
Tissue-specific gene delivery via nanoparticle coating.
@en
P2093
P2860
P1433
P1476
Tissue-specific gene delivery via nanoparticle coating.
@en
P2093
Daniel G Anderson
Jordan J Green
Peter W Fung
Sangeeta N Bhatia
Todd J Harris
P2860
P304
P356
10.1016/J.BIOMATERIALS.2009.10.012
P577
2009-10-21T00:00:00Z